Literature DB >> 9141542

Spontaneous feminization in a 46,XX female patient with congenital lipoid adrenal hyperplasia due to a homozygous frameshift mutation in the steroidogenic acute regulatory protein.

H S Bose1, O H Pescovitz, W L Miller.   

Abstract

The most severe form of congenital adrenal hyperplasia (CAH) is lipoid CAH. It was once thought that this disease was due to mutations in the cholesterol side-chain cleavage enzyme system, thus eliminating the ability to convert cholesterol to pregnenolone, causing a complete absence of steroid hormone production. We recently showed that lipoid CAH is due to mutations in the steroidogenic acute regulatory (StAR) protein, thus preventing acutely stimulated adrenal and gonadal responses to tropic stimulation. However, this lesion may permit low levels of StAR-independent steroidogenesis to persist until the accumulation of intracellular lipid deposits destroys steroidogenic capacity. This model would predict that the steroidogenic cells of the ovaries of affected 46,XX females should remain undamaged until puberty, at which time low levels of StAR-independent estrogen biosynthesis should be detectable. We describe a 15.5-yr-old 46,XX female with a classic history of lipoid CAH who underwent spontaneous feminization and cyclical vaginal bleeding beginning at age 13. Genetic analysis of the patient and her parents showed that she was homozygous for the novel StAR frameshift mutation 261delT. This is the first adolescent female with lipoid CAH who has undergone spontaneous feminization and who has been analyzed genetically. Finding an inactive StAR gene in this patient confirms our two-hit model of the pathogenesis of lipoid CAH, in which loss of StAR activity initially preserves StAR-independent steroidogenesis, which is lost only after cells undergo chronic tropic stimulation and subsequent damage from accumulation of cholesterol esters.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9141542     DOI: 10.1210/jcem.82.5.3962

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  26 in total

1.  The active form of the steroidogenic acute regulatory protein, StAR, appears to be a molten globule.

Authors:  H S Bose; R M Whittal; M A Baldwin; W L Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

2.  Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia.

Authors:  K M Caron; S C Soo; W C Wetsel; D M Stocco; B J Clark; K L Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 3.  Role of the steroidogenic acute regulatory protein in health and disease.

Authors:  Pulak R Manna; Cloyce L Stetson; Andrzej T Slominski; Kevin Pruitt
Journal:  Endocrine       Date:  2015-08-14       Impact factor: 3.633

Review 4.  Monogenic Disorders of Adrenal Steroidogenesis.

Authors:  Elizabeth S Baranowski; Wiebke Arlt; Jan Idkowiak
Journal:  Horm Res Paediatr       Date:  2018-06-06       Impact factor: 2.852

5.  Clinical, genetic, and functional characterization of four patients carrying partial loss-of-function mutations in the steroidogenic acute regulatory protein (StAR).

Authors:  Taninee Sahakitrungruang; Raymond E Soccio; Mariarosaria Lang-Muritano; Joanna M Walker; John C Achermann; Walter L Miller
Journal:  J Clin Endocrinol Metab       Date:  2010-05-05       Impact factor: 5.958

Review 6.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

7.  Nonclassic congenital lipoid adrenal hyperplasia: a new disorder of the steroidogenic acute regulatory protein with very late presentation and normal male genitalia.

Authors:  Bo Yang Baker; Lin Lin; Chan Jong Kim; Jamal Raza; Claire P Smith; Walter L Miller; John C Achermann
Journal:  J Clin Endocrinol Metab       Date:  2006-09-12       Impact factor: 5.958

8.  Partial defect in the cholesterol side-chain cleavage enzyme P450scc (CYP11A1) resembling nonclassic congenital lipoid adrenal hyperplasia.

Authors:  Taninee Sahakitrungruang; Meng Kian Tee; Piers R Blackett; Walter L Miller
Journal:  J Clin Endocrinol Metab       Date:  2010-12-15       Impact factor: 5.958

9.  Varied clinical presentations of seven patients with mutations in CYP11A1 encoding the cholesterol side-chain cleavage enzyme, P450scc.

Authors:  Meng Kian Tee; Michal Abramsohn; Neta Loewenthal; Mark Harris; Sudeep Siwach; Ana Kaplinsky; Barak Markus; Ohad Birk; Val C Sheffield; Ruti Parvari; Ruti Pavari; Eli Hershkovitz; Walter L Miller
Journal:  J Clin Endocrinol Metab       Date:  2013-01-21       Impact factor: 5.958

Review 10.  Basic concepts and recent developments in human steroid hormone biosynthesis.

Authors:  Hans K Ghayee; Richard J Auchus
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.